Levobel: UK Status and Risks
Levobel is not a UK-licensed product for sale in the UK. It can still show up in some listings, but the MHRA has not assessed its safety or effectiveness.
Check with a pharmacist before acting on it, and check who you are buying from before paying. An unclear licensing status should not be assumed to mean approval.
Not UK-licensed. This medicine is not supplied through UK-registered pharmacies.
Sellers list the active ingredient as levosulpiride. The MHRA has not assessed what these products actually contain.
The MHRA warns that medicines sold outside registered pharmacies can be counterfeit, contaminated, or contain the wrong amount of active ingredient. Buy prescription-only medicines from a pharmacy registered in the UK.
Pharmacies by area for Levobel (UK-licensed equivalent)
- North East · 884 pharmacies
- North West · 2538 pharmacies
- Yorkshire and The Humber · 1676 pharmacies
- East Midlands · 1307 pharmacies
- West Midlands · 1778 pharmacies
- East of England · 1860 pharmacies
- London · 3261 pharmacies
- South East · 2368 pharmacies
- South West · 1374 pharmacies
- Northern Ireland · 714 pharmacies
- Scotland · 1725 pharmacies
- Wales · 1050 pharmacies
Pharmacies near you
Use your location to open the pharmacies closest to you and ask them about Levobel, the UK-licensed medicine with the same active ingredient.
Cities with the most pharmacies
- London · 724 pharmacies
- Birmingham · 265 pharmacies
- Nottingham · 180 pharmacies
- Glasgow · 177 pharmacies
- Leeds · 173 pharmacies
- Sheffield · 162 pharmacies
- Bristol · 148 pharmacies
- City of London · 144 pharmacies
- Manchester · 134 pharmacies
- Edinburgh · 131 pharmacies
- Bolton · 124 pharmacies
- Belfast · 122 pharmacies
- Hampstead · 121 pharmacies
- Coventry · 115 pharmacies
- Cardiff · 112 pharmacies
About Levobel
Levobel is not a licensed medicine in the United Kingdom and cannot legally be sold there as a medicine. Its active ingredient, pharmacological class, formulation and strengths are not identified.
No marketed treatment indication is listed. These gaps prevent a reliable assessment of its intended effects, interactions or suitability, and warrant discussion with a doctor or pharmacist before considering its use.
Claimed strengths are manufacturer claims, but no strengths are listed for Levobel. Its dosage form is also not listed, so there is no basis for describing a tablet, capsule, liquid or other preparation.
No licensed equivalent is identified for comparison. A dosing recommendation cannot be established from these details.
What Levobel is used for
No marketed use or claimed treatment indication is listed for Levobel. It is therefore not possible to describe a condition it is marketed for, or distinguish a promotional claim from an established medical use.
The name alone does not establish what the product contains or what it is intended to do. Any treatment claim seen in advertising would need to be assessed alongside a clearly identified active ingredient and reliable evidence.
How Levobel works
Levobel has no identified active ingredient or pharmacological class, so a mechanism of action cannot be described reliably. Medicines work through different processes, such as affecting chemical signals, enzymes or receptors, but none of these mechanisms can be attributed to this product from its name alone. Assigning it the effects of a similarly named medicine would risk giving a misleading account of both its potential benefits and its risks.
Main interactions
- Interactions with prescription medicines cannot be assessed because the active ingredient is unidentified.
- Interactions with non-prescription medicines, herbal products and supplements cannot be assessed.
- Potential interactions with alcohol or food are not established for this product.
Key warnings
- Levobel lacks licensing as a medicine in the United Kingdom, and independent verification of its contents is not established.
- The active ingredient is not identified, preventing a reliable assessment of adverse effects.
- No formulation or strength is listed, preventing assessment of the amount of any active ingredient.
- An unidentified product cannot be assumed suitable alongside existing medicines or medical conditions.
Pregnancy and breastfeeding
The marketing material does not specify pregnancy or breastfeeding data for Levobel. Because its active ingredient is unidentified, effects on pregnancy, a breastfed child or milk production cannot be assessed. Any proposed use during pregnancy or breastfeeding should be discussed with a doctor or pharmacist.
Missed dose
No missed-dose guidance can be established for Levobel because its active ingredient, formulation and dosing directions are not identified. Advice for another medicine should not be applied on the basis of a similar name. A doctor or pharmacist can assess the packaging and clarify whether any medicine-specific guidance is appropriate.
Storage
No storage conditions are listed for Levobel, and its dosage form is unidentified. General precautions include keeping products in their original packaging, away from children, and following any storage directions on the label to maintain quality.
Related medicines
First published October 2, 2026 · Last updated · Report an error on this page